IGF1 and Obesity: The reasons behind the poor treatment outcome are not fully understood; however, obesity is associated with the systemic elevation of insulin-like growth factor 1 (IGF-1), adipokines, cytokines, and pro-angiogenic factors, which create a pro-oncogenic environment [8].